• Home

Related articles

  • Challenges in HPV Vaccine Development and Supply

    PM Kotulka, A Luxembourg, A Shaw

  • Current status of HPV vaccine in China

    YL Qiao, MJ Gonzalez-Mendez, YQ Yu

  • Efficacy of HPV Vaccination To Prevent Vulvar and Vaginal Precancer

    L Xu, SM Garland, M Arbyn

  • Impact of Bivalent HPV Vaccination in Scotland

    R Cameron, K Cuschieri, K Roy

  • The impact of HPV vaccination program on CIN3 and cervical cancer incidence in England

    K. Soldan, L. Elliss-Brookes, P. Sasieni

  • The value of HPV vaccines for the elimination of cervical cancer in China

    H Yan, F Zhao, Y Qiao

  • Interview with Elmar Joura

    EA Joura

  • Prevention of HPV-Related Diseases Following 4-Valent Vaccination in Australia

    SM Garland, GL Murray, DA Machalek

  • Population-level Impact and Herd Effects of HPV Vaccination Programs in High-income Countries: Real-life Data

    M Drolet, M Brisson

  • Pre-school HPV Immunization?

    MA Kane, M Stanley

  • The time to act is now: elimination of cervical and other cancers caused by HPV in women and men

    AR Giuliano, EA Joura

  • HPV vaccination crisis and recovery: the Danish case

    L Baandrup, P Valentiner-Branth, SK Kjaer

  • HOME
  • Published material
  • Remembering our colleagues
  • About us
  • Contact us

Login

Change email Change password Activate service

Did you forget your password?

Do you want to subscribe?

Legal noticePrivacy Policy
Copyright © 2023 HPV World All rights reserved